Vulvar cancer is a relatively rare gynaecologic cancer affecting the external female genital organs, particularly the labia, clitoris, and vaginal opening. Most cases are squamous cell carcinomas, which originate in the thin, flat cells lining the vulva. Vulvar cancer primarily affects older women but can occur at any age.
Timely diagnosis and treatment can significantly improve outcomes. However, due to limited awareness, the condition is often diagnosed at a later stage. Understanding the signs, risk factors, and modern treatment methods can empower women to seek medical advice early.
Vulvar cancer occurs when abnormal cells grow uncontrollably in the tissues of the vulva. The vulva includes the outer lips of the vagina (labia majora and labia minora), clitoris, and vaginal opening. It often starts as precancerous changes called vulvar intraepithelial neoplasia (VIN), which can develop into invasive cancer over time.
There are several histological types of vulvar cancer:
Vulvar cancer is rare in India but not negligible. According to the National Cancer Registry Programme, vulvar cancer accounts for approximately 3-5% of all gynaecological cancers. It is more frequently diagnosed in women aged 60 and above.
Globally, vulvar cancer represents about 4% of all gynaecologic cancers. The American Cancer Society estimates around 6,000 new cases are diagnosed annually in the United States alone. Higher rates are observed in older women and in regions with better access to screening.
Vulvar cancer is usually caused by changes (mutations) in the DNA of vulvar cells. These mutations can be influenced by:
Early symptoms may mimic other less serious conditions, making it difficult to diagnose. Common symptoms include:
While not a replacement for medical treatment, alternative therapies may provide symptom relief and emotional support:
Early consultation leads to timely diagnosis and treatment.
Vulvar cancer, though rare, is a serious condition that warrants awareness and timely intervention. With advancements in medical science, early-stage vulvar cancer is highly treatable. Women should be encouraged to speak openly about symptoms and undergo regular gynaecological examinations. Education, emotional support, and early treatment can make a world of difference in improving outcomes and quality of life.